Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Muscleblind-like protein 1 (MBNL1)-expanded RNA repeat complex is a pathological ribonucleoprotein assembly central to the pathogenesis of Myotonic Dystrophy (DM) (Miller et al., 2000; Kanadia et al., 2003). In DM, expanded CUG or CCUG repeats in the 3' untranslated region of the DMPK or CNBP genes form stable hairpin structures that sequester MBNL1 within nuclear foci (UniProt Q9NR56). This sequestration leads to a functional loss of MBNL1, a critical regulator of alternative splicing, resulting in the mis-splicing of numerous downstream transcripts such as CLCN1 and INSR (NIH/GARD). Therapeutic strategies targeting this complex aim to either degrade the toxic expanded RNA or use small molecules to competitively inhibit the MBNL1-RNA interaction, thereby liberating the protein to restore normal cellular function (Warf et al., 2009). Restoring MBNL1 activity is expected to alleviate the multisystemic symptoms of DM, including myotonia, muscle wasting, and cardiac conduction defects. However, challenges include achieving high specificity for the expanded repeats over other RNA sequences and ensuring efficient delivery to affected tissues like skeletal and cardiac muscle.
Disruption of the MBNL1-RNA complex to release sequestered MBNL1 and restore normal alternative splicing patterns.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscleblind-like protein 1-expanded RNA repeat complex (MBNL1-RNA complex).